Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin J Czogalla

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nutrients|August 20, 2015
Structural Modeling Insights into Human VKORC1 PhenotypesKatrin J Czogalla, Matthias Watzka, Johannes Oldenburg
International Journal of Molecular Sciences|January 21, 2022
The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 PhenotypesSuvoshree Ghosh, Johannes Oldenburg, Katrin J Czogalla-Nitsche
Blood|June 26, 2014
The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motifKatrin J Czogalla, Arijit Biswas, Simone Rost, et al.
Thrombosis Research|March 10, 2015
Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brainMichael Caspers, Katrin J Czogalla, Kerstin Liphardt, et al.
Nature Structural & Molecular Biology|December 13, 2016
Warfarin and vitamin K compete for binding to Phe55 in human VKORKatrin J Czogalla, Arijit Biswas, Klara Höning, et al.
Blood Advances|March 28, 2018
VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sitesKatrin J Czogalla, Kerstin Liphardt, Klara Höning, et al.
Blood|August 29, 2013
Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfacesKatrin J Czogalla, Arijit Biswas, Ann-Christin Wendeln, et al.
Frontiers in Cell and Developmental Biology|February 15, 2021
Menaquinone-7 Supplementation Improves Osteogenesis in Pluripotent Stem Cell Derived Mesenchymal Stem CellsAsim Cengiz Akbulut, Grzegorz B Wasilewski, Nikolas Rapp, et al.
Annals of Hematology|February 17, 2018
Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutationsBehnaz Pezeshkpoor, Katrin J Czogalla, Michael Caspers, et al.
Scientific Reports|June 19, 2026
VKORC1L1-mediated vitamin K recycling counters ferroptosis to promote endothelial repairElena Repges, Adem Aksoy, Katrin J Czogalla-Nitsche, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nutrients|August 20, 2015
Structural Modeling Insights into Human VKORC1 PhenotypesKatrin J Czogalla, Matthias Watzka, Johannes Oldenburg
International Journal of Molecular Sciences|January 21, 2022
The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 PhenotypesSuvoshree Ghosh, Johannes Oldenburg, Katrin J Czogalla-Nitsche
Blood|June 26, 2014
The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motifKatrin J Czogalla, Arijit Biswas, Simone Rost, et al.
Thrombosis Research|March 10, 2015
Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brainMichael Caspers, Katrin J Czogalla, Kerstin Liphardt, et al.
Nature Structural & Molecular Biology|December 13, 2016
Warfarin and vitamin K compete for binding to Phe55 in human VKORKatrin J Czogalla, Arijit Biswas, Klara Höning, et al.
Blood Advances|March 28, 2018
VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sitesKatrin J Czogalla, Kerstin Liphardt, Klara Höning, et al.
Blood|August 29, 2013
Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfacesKatrin J Czogalla, Arijit Biswas, Ann-Christin Wendeln, et al.
Frontiers in Cell and Developmental Biology|February 15, 2021
Menaquinone-7 Supplementation Improves Osteogenesis in Pluripotent Stem Cell Derived Mesenchymal Stem CellsAsim Cengiz Akbulut, Grzegorz B Wasilewski, Nikolas Rapp, et al.
Annals of Hematology|February 17, 2018
Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutationsBehnaz Pezeshkpoor, Katrin J Czogalla, Michael Caspers, et al.
Scientific Reports|June 19, 2026
VKORC1L1-mediated vitamin K recycling counters ferroptosis to promote endothelial repairElena Repges, Adem Aksoy, Katrin J Czogalla-Nitsche, et al.
Pageof 2